$4.00 Target around August 6-10Based on the timing on the last two booms and the overall bullish MA. I'm predicting a run up to around $4.00 by this time next month. Longby rtaylo3
Zoom out for a better perspective if you're longThis stock has plenty of fluctuation from day to day, but long term it's trending upwards. Longby rtaylo4
PDSB Boom Compared with NVAXThis stock was following NVAX closely today. With an explosive open and holding strong, this stock is poised to moved higher. Comparing this stock to NVAX is like having a crystal ball. Longby rtaylo4
PDS Biotechnology Corp. 25% upsidePDS Biotechnology Corp. engages in the development of clinical-stage immunotherapies to treat various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products PDS0101, is an off the shelf immunotherapeutic that is administered by subcutaneous injection. The company was founded by Frank K. Bedu-Addo on March 15, 2019 and is headquartered in Princeton, NJ.Longby DEXWireNews1112
PDSB Positive NewsPositive news today for PDSB "PDS Biotechnology Announces Publication Supporting Novel Mechanisms of Action of its Proprietary Versamune® Platform in Cancer Immunotherapy". Shs Float 1.42M, Market Cap 14.24M. Watching for continuation.by TradeWithTyler2